NCT06334432 - Safety and Efficacy Study of NUV-1511 in Adult Patients With Advanced Solid Tumors | Biotech Hunter

Enrollment

466

Participants

Timeline

Start Date

March 14, 2024

Primary Completion Date

March 31, 2027

Study Completion Date

October 31, 2027

Conditions

Advanced Solid TumorHER2-negative Breast CancerMetastatic Castration-resistant Prostate Cancer (mCRPC)Pancreatic CancerPlatinum-resistant Ovarian Cancer (PROC)

Interventions

DRUG

NUV-1511

Novel small molecule

Trial Locations (8)

10065

RECRUITING

Memorial Sloan-Kettering Cancer Center, New York

22031

RECRUITING

NEXT Oncology, Fairfax

28078

RECRUITING

Carolina BioOncology Institute, Huntersville

48201

RECRUITING

Karmanos Cancer Center, Detroit

75038

RECRUITING

NEXT Oncology, Irving

84124

RECRUITING

START Mountain, Salt Lake City

98109

RECRUITING

Fred Hutchinson, Seattle

07601

RECRUITING

Hackensack University Medical Center, Hackensack